Wear debris inhibition of anti-osteoclastogenic signaling by interleukin-6 and interferon-γ -: Mechanistic insights and implications for periprosthetic osteolysis

被引:64
作者
Rakshit, DS
Ly, K
Sengupta, TK
Nestor, BJ
Sculco, TP
Ivashkiv, LB
Purdue, PE
机构
[1] Hosp Special Surg, Osteolysis Res Lab, New York, NY 10021 USA
[2] Philip Morris USA Res Ctr, Richmond, VA 23234 USA
关键词
D O I
10.2106/JBJS.E.00711
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Wear debris challenge of macrophages provokes the generation of proinflammatory cytokines, which contribute to periprosthetic osteolysis. However, it is not known whether this effect is accompanied by reprogramming of other cytokines present within the periprosthetic tissue that may be involved in anti-osteoclastogenic activities. In the present study, we examined the ability of wear debris particles to inhibit the signaling of two such cytokines, interleukin-6 and interferon-gamma. Methods: Human osteoclast precursor cells were challenged with particles of titanium or polymethylmethacrylate bone cement prior to the addition of the cytokines interleukin-6 or interferon-gamma. Interleukin-6 signaling was determined by measuring the activation of STAT3 signal transduction with use of immunoblotting and electrophoretic mobility shift assays. Interferon-gamma signaling was determined by measuring the activation of STAT1 with use of immunoblotting and electrophoretic mobility shift assays and by measuring the expression of interferon-gamma-inducible genes with use of real-time reverse transcription-polymerise chain reaction assays. Involvement of mitogen-activated protein kinases in cytokine signaling was assessed by including mitogen-activated protein kinase inhibitors in these assays and also by means of immunoblot assessment of mitogen-activated protein kinase activation by wear debris particles. Wear debris modulation of expression of the cytokine suppressors SOCS1 and SOCS3 (as well as pro-inflammatory mediators) was assessed with use of real-time reverse transcription-polymerise chain reaction assays. Results: Both titanium and polymethyl methacrylate particles potently inhibited interleukin-6-induced STAT3 activation in human osteoclast precursor cells. Inhibition of p38 mitogen-activated protein kinase, which is activated by titanium and polymethylmethacrylate, reversed the inhibitory effects of these particles on interleukin-6 signaling, whereas inhibition of ERK and JNK mitogen-activated protein kinases (which are also activated by both types of wear debris) had no effect. Titanium and polymethylmethacrylate also both induced expression of SOCS3, an inhibitor of interleukin-6 signaling. In addition to its effects on interleukin-6 signaling, titanium also profoundly inhibited the interferon-gamma-induced activation of STAT1 and the expression of interferon-gamma-inducible genes, whereas polymethylmethacrylate had no effect on interferon-gamma signaling. Conclusions: Titanium inhibits both interferon-gamma and interleukin-6 signaling in human osteoclast precursor cells, whereas polymethylmethacrylate bone cement inhibits only the latter. Wear particle inhibition of interleukin-6 specifically involves the activation of p38 mitogen-activated protein kinase and is accompanied by substantial induction of SOCS3, an inhibitor of interleukin-6 signaling. In contrast, titanium inhibition of interferon-gamma signaling is not dependent on mitogen-activated protein kinase activation and is accompanied by only modest induction of the interferon-gamma inhibitor SOCS1. Clinical Relevance: The critical role of wear debris in the development of periprosthetic osteolysis likely involves the inhibition of anti-inflammatory/anti-osteoclastogenic cytokine signaling in addition to the well-established induction of pro-inflammatory mediators. Strategies to augment these "protective" signaling pathways may therefore have therapeutic potential for the treatment of periprosthetic osteolysis.
引用
收藏
页码:788 / 799
页数:12
相关论文
共 42 条
[1]   Inhibition of IL-6 and IL-10 signaling and Stat activation by inflammatory and stress pathways [J].
Ahmed, ST ;
Ivashkiv, LB .
JOURNAL OF IMMUNOLOGY, 2000, 165 (09) :5227-5237
[2]   Kinetics of IL-10-induced gene expression in human macrophages [J].
Antoniv, TT ;
Park-Min, KH ;
Ivashkiv, LB .
IMMUNOBIOLOGY, 2005, 210 (2-4) :87-95
[3]   Increased levels of tumor necrosis factor-alpha and interleukin-6 protein and messenger RNA in human peripheral blood monocytes due to titanium particles [J].
Blaine, TA ;
Rosier, RN ;
Puzas, JE ;
Looney, RJ ;
Reynolds, PR ;
Reynolds, SD ;
OKeefe, RJ .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1996, 78A (08) :1181-1192
[4]   Osteoclast differentiation and activation [J].
Boyle, WJ ;
Simonet, WS ;
Lacey, DL .
NATURE, 2003, 423 (6937) :337-342
[5]   PGE2 and IL-6 production by fibroblasts in response to titanium wear debris particles is mediated through a Cox-2 dependent pathway [J].
Bukata, SV ;
Gelinas, J ;
Wei, XC ;
Rosier, RN ;
Puzas, JE ;
Zhang, XP ;
Schwarz, EM ;
Song, XYR ;
Griswold, DE ;
O'Keefe, RJ .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2004, 22 (01) :6-12
[6]  
CHIBA J, 1994, CLIN ORTHOP RELAT R, P304
[7]   In vivo RANK signaling blockade using the receptor activator of NF-κB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis [J].
Childs, LM ;
Paschalis, EP ;
Xing, LP ;
Dougall, WC ;
Anderson, D ;
Boskey, AL ;
Puzas, JE ;
Rosier, RN ;
O'Keefe, RJ ;
Boyce, BF ;
Schwarz, EM .
JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (02) :192-199
[8]   Efficacy of etanercept for wear debris-induced osteolysis [J].
Childs, LM ;
Goater, JJ ;
O'Keefe, RJ ;
Schwarz, EM .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (02) :338-347
[9]   NF-kB signaling blockade abolishes implant particle-induced osteoclastogenesis [J].
Clohisy, JC ;
Hirayama, T ;
Frazier, E ;
Han, SK ;
Abu-Amer, Y .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2004, 22 (01) :13-20
[10]   The possible role of TGF-β-induced suppressors of cytokine signaling expression in osteoclast/macrophage lineage commitment in vitro [J].
Fox, SW ;
Haque, SJ ;
Lovibond, AC ;
Chambers, TJ .
JOURNAL OF IMMUNOLOGY, 2003, 170 (07) :3679-3687